USANA Health Sciences, Inc. (USNA)

NYQ – Real Time Price. Currency in USD

14.09

+0.33 (2.40%)

Market open: Aug 12, 2026, 12:32 PM EDT

13.76

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Stock details

Previous close: 13.76$
Day's range: 13.73 - 14.4$
52-week range: 13.73 - 32.32$
Volume: 345 233
Average volume: 260 581
Beta: 0.71
EPS (TTM): -1.2
PE ratio (TTM): N/A
Forward P/E: 18.11
Market cap: 254 051 033
Shares outstanding: 18 463 011
Dividend yield: N/A
Next earnings date: 2026-10-27
Sector: Consumer Staples
Industry: Packaged Foods

About the company

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as ... read more

CEO: Kevin Guest
Country: United States
IPO Date: 1996-07-25
Employees: 1570
Fiscal Year End: February - January
Website: https://www.usana.com

Revenue Breakdown

Core Nutritional / 83.81%

Hiya Direct-to-consumer / 14.26%

Other / 1.93%

News

No Data

There are no news for this stock.

Chart: USNA

Loading Chart...

Overall Score

3.9 / 1039%

Octagon View

Strength & Weakness

Cash reserves $168.6M barely cover the upcoming debt maturities $0.0

Total current assets $281.1M exceed Total current liabilities $105.7M, highlighting excellent liquidity

Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage

The company has no interest-bearing debt, showcasing excellent financial strength

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	2.66	5.22	10
Quick ratio	1.84	3.57	9.0
Debt to Equity	0.00	0.37	10
Debt to Assets	0.00	3.57	10
Interest coverage	N/A	33.35	10
Weighted average score			9.8

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	999M	921M	855M	925M	913M
Gross Profit	791M	732M	679M	692M	683M
Operating Income	108M	93M	66M	51M	41M
Net Income	69M	64M	42M	11M	-22M
EBITDA	129M	113M	89M	91M	80M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	78.35	19.81	10
Operating margin %	4.09	-13.86	3.0
Net margin %	-9.58	-17.73	1.0
EBITDA margin %	8.20	-24.76	3.0
Cash flow margin %	N/A	-8.20	1.0
Weighted average score			3.6

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	0.50	-15.60	2.0
ROE	0.65	-57.50	2.0
ROIC	3.32	2.64	5.0
ROCE	1.69	13.11	4.0
Weighted average score			3.3

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	2.35	173.33	6.5
Next quarter	-4.04	-81.67	1.0
Current year	-1.7	-60.62	1.0
Next year	4.43	132.89	7.0
Weighted average score			3.9

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	-10.76	-384.51	-111.47	215.02	3.3
Y/Y	-5.32	-321.45	-109.45	-43.88	1.0
3y average	-2.22	-38.82	-18.34	-44.15	1.0
5y average	-3.58	-32.69	-18.91	-34.31	1.0
Weighted average score					1.6

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	28.68	-13.04	4.0
PEG (5yr expected)	1.10	15.59	6.0
P/S	0.28	14.21	9.4
P/B	0.50	-6.06	9.0
Weighted average score			7.1

DCF Model

DCF Model Period5 years

Discount rate8.5%

Perpetual growth rate3%

Revenue 5 year CAGR-0.2%

FCF 5 year CAGR4

Fair value59.12$

Stock price14.1$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	0.00	N/A	1.0
Payout ratio	0.00	N/A	1.0
5-year dividend growth rate	N/A	N/A	1.0
Years of dividend increase	N/A	N/A	1.0
Weighted average score			1.0

Fair Value

$59.12

UndervaluedStock priceOvervalued

$14.1

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Kevin Guest

Country

United States

IPO Date

1996-07-25

Employees

1570

Fiscal Year End

February - January

Website

https://www.usana.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

2.66

5.22

Quick ratio

1.84

3.57

9.0

Debt to Equity

0.00

0.37

Debt to Assets

0.00

3.57

Interest coverage

N/A

33.35

Weighted average score

9.8

METRIC

2022

2023

2024

2025

TTM

Total Revenue

999M

921M

855M

925M

913M

Gross Profit

791M

732M

679M

692M

683M

Operating Income

108M

93M

66M

51M

41M

Net Income

69M

64M

42M

11M

-22M

EBITDA

129M

113M

89M

91M

80M

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

78.35

19.81

Operating margin %

4.09

-13.86

3.0

Net margin %

-9.58

-17.73

1.0

EBITDA margin %

8.20

-24.76

3.0

Cash flow margin %

N/A

-8.20

1.0

Weighted average score

3.6

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

0.50

-15.60

2.0

ROE

0.65

-57.50

2.0

ROIC

3.32

2.64

5.0

ROCE

1.69

13.11

4.0

Weighted average score

3.3

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

2.35

173.33

6.5

Next quarter

-4.04

-81.67

1.0

Current year

-1.7

-60.62

1.0

Next year

4.43

132.89

7.0

Weighted average score

3.9

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

-10.76

-384.51

-111.47

215.02

3.3

Y/Y

-5.32

-321.45

-109.45

-43.88

1.0

3y average

-2.22

-38.82

-18.34

-44.15

1.0

5y average

-3.58

-32.69

-18.91

-34.31

1.0

Weighted average score

1.6

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

28.68

-13.04

4.0

PEG (5yr expected)

1.10

15.59

6.0

P/S

0.28

14.21

9.4

P/B

0.50

-6.06

9.0

Weighted average score

7.1

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

0.00

N/A

1.0

Payout ratio

0.00

N/A

1.0

5-year dividend growth rate

N/A

1.0

Years of dividend increase

N/A

1.0

Weighted average score

1.0

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

USANA Health Sciences, Inc. (USNA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

USANA Health Sciences, Inc. (USNA)

Stock details

About the company

Revenue Breakdown

News

Chart: USNA

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$59.12

$14.1

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: USNA

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$59.12

$14.1

Economic Moat